Davidson Kempner Partners’s BioPlus Acquisition Corp. Warrants BIOSW Stock Holding History

Davidson Kempner Partners’s Portfolio BIOSW Stock Details BIOSW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	$20K	Buy	+250,000	New	+$20.1K	﹤0.01%	282

Other funds holding BIOSW

Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return

Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Calamos Advisors

Calamos Advisors Naperville, Illinois $28.2B AUM 21.78% 1-Year Est. Return

Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return

Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return

Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Davidson Kempner Partners's BIOSW Position: Q1 2023 in Review

Davidson Kempner Partners opened a new position in BioPlus Acquisition Corp. Warrants (BIOSW) in Q1 2023: 250,000 shares worth $20K. The stake represents ﹤0.01% of the portfolio and ranks #282 among its holdings.

43 funds tracked by Wall St. Rank hold BIOSW as of Q1 2023.

Davidson Kempner Partners held 250,000 shares of BioPlus Acquisition Corp. Warrants worth $20K as of Q1 2023.
BioPlus Acquisition Corp. Warrants was a new Davidson Kempner Partners position in Q1 2023.
BioPlus Acquisition Corp. Warrants made up ﹤0.01% of Davidson Kempner Partners's portfolio in Q1 2023, its #282 holding.
43 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Warrants as of Q1 2023.

Based on Davidson Kempner Partners's 13F filing for Q1 2023, filed 15 May 2023.